Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Shpitz

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Transplantation|October 27, 1997
Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse modelS Dessureault, B Shpitz, J Alloo, et al.
Anticancer Research|February 1, 2000
Oncoprotein coexpression in human aberrant crypt foci and minute polypoid lesions of the large bowelB Shpitz, Y Bomstein, M Shalev, et al.
Diseases of the Colon and Rectum|July 1, 1996
Natural history of aberrant crypt foci. A surgical approachB Shpitz, K Hay, A Medline, et al.
Human Pathology|May 22, 1998
Aberrant crypt foci in human colons: distribution and histomorphologic characteristicsB Shpitz, Y Bomstein, Y Mekori, et al.
Gut|October 23, 2003
Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancerB Shpitz, E Klein, G Buklan, et al.
International Journal of Cancer|November 10, 1998
Controlled release of TGF-beta1 impedes rat colon carcinogenesis in vivoR Mikhailowski, B Shpitz, S Polak-Charcon, et al.
Nuclear Medicine Communications|May 1, 1994
Immunoscintigraphy of human colon cancer xenografts in nude mice using a second-generation TAG-72 monoclonal antibody labelled with 99TcmR M Reilly, K Ng, J Polihronis, et al.
The Journal of Surgical Research|February 15, 1996
Cytotoxicity of B72.3XOKT3 bispecific antibody recognizing human colon cancerB Shpitz, H Stern, J S Sandhu, et al.
Carcinogenesis|September 1, 1993
K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesisA A Vivona, B Shpitz, A Medline, et al.
Surgical Oncology|June 1, 1992
Intra-rectal injection of tumour cells: a novel animal model of rectal cancerH Kashtan, M Rabau, J B Mullen, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Transplantation|October 27, 1997
Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse modelS Dessureault, B Shpitz, J Alloo, et al.
Anticancer Research|February 1, 2000
Oncoprotein coexpression in human aberrant crypt foci and minute polypoid lesions of the large bowelB Shpitz, Y Bomstein, M Shalev, et al.
Diseases of the Colon and Rectum|July 1, 1996
Natural history of aberrant crypt foci. A surgical approachB Shpitz, K Hay, A Medline, et al.
Human Pathology|May 22, 1998
Aberrant crypt foci in human colons: distribution and histomorphologic characteristicsB Shpitz, Y Bomstein, Y Mekori, et al.
Gut|October 23, 2003
Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancerB Shpitz, E Klein, G Buklan, et al.
International Journal of Cancer|November 10, 1998
Controlled release of TGF-beta1 impedes rat colon carcinogenesis in vivoR Mikhailowski, B Shpitz, S Polak-Charcon, et al.
Nuclear Medicine Communications|May 1, 1994
Immunoscintigraphy of human colon cancer xenografts in nude mice using a second-generation TAG-72 monoclonal antibody labelled with 99TcmR M Reilly, K Ng, J Polihronis, et al.
The Journal of Surgical Research|February 15, 1996
Cytotoxicity of B72.3XOKT3 bispecific antibody recognizing human colon cancerB Shpitz, H Stern, J S Sandhu, et al.
Carcinogenesis|September 1, 1993
K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesisA A Vivona, B Shpitz, A Medline, et al.
Surgical Oncology|June 1, 1992
Intra-rectal injection of tumour cells: a novel animal model of rectal cancerH Kashtan, M Rabau, J B Mullen, et al.
Pageof 6